#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Barth syndrome Liposarcoma Gestational trophoblastic tumour Neurodevelopmental disorder Short stature homeobox gene mutation Loeys-Dietz syndrome Vascular calcification Raynaud's phenomenon Hypoparathyroidism Spinal cord injury Nephropathy Factor IX deficiency Ovarian epithelial cancer MELAS syndrome Arginase deficiency More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Trials in Disease Rhabdomyosarcoma Chordoma – Life with Disease Nodal marginal zone B-cell lymphoma – Treatment Leiomyosarcoma recurrent Rhabdomyosarcoma – Life with Disease Osteosarcoma metastatic – Diagnostics Mucopolysaccharidosis III – Life with Disease Glomerulonephritis membranous – Treatment Metachromatic leukodystrophy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mianserin Hydrochloride Suvecaltamide ELTANEXOR Hu5F9‐G4 Ulipristal Acetate Golcadomide Cobamamide Metoclopramide Hydrochloride Paeonol Hydrocortisone Ph. Eur. Afamelanotide Enzalutamide Bi 1839100 Prilocaine SEVABERTINIB Tofogliflozin Ipratropium Bromide Rilpivirine Hydrochloride Fenfluramine Hydrochloride Entinostat More therapies…

    Learn about Your Condition

    Knee arthroplasty Cognitive disorder Palpitations Circulatory collapse Skin ulcer Kearns-Sayre syndrome Diminished ovarian reserve Nephrotic syndrome Eye pain Arteriosclerosis Giardiasis Lyme disease Retroperitoneal cancer Pyoderma gangrenosum Breast cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer’s Disease over 72 weeks

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • VHB937
    Czechia France Germany Italy The Netherlands Poland +2

  • Study of Atomoxetine to Reduce Freezing of Gait in Patients with Parkinson’s Disease During OFF-State

    Recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Atomoxetine
    The Netherlands

  • Study of Flumazenil to Reduce Side Effects of Electroconvulsive Therapy in Patients with Depression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Denmark

  • Study on the Effects of THC and CBD Oral Solution for Chronic Neuropathic Pain in Multiple Sclerosis Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Neuralgia
    • Multiple sclerosis
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Portugal

  • Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

    Recruiting

    4 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • JX10
    Belgium Bulgaria Finland France Germany Greece +7

  • Study on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy

    Recruiting

    3 1
    Investigated Diseases:
    • Epileptic encephalopathy
    Belgium France Germany Italy Latvia The Netherlands +2
Previous Page
1 … 14 15 16 17 18 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!